过去一年中添加的文章,按日期排序

Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway

J Liu, J Fu, P Fu, M Liu, Z Liu, B Song - Cancer Cell International, 2024 - Springer
41 天前 - … A class of drugs known as “statinsinhibit lipid cholesterol … Cell culture and
animal-related studies validated that the … was activated in PC9GR cells relative to PC9 cells, and …

[HTML][HTML] Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation

DZ Dos Santos, M Elbaz, E Branchard… - Biomedicine & …, 2024 - Elsevier
53 天前 - … and enhance the pro-apoptotic activity of statins, we performed a … -mimetic drugs
that inhibit SREBP2 activation upon statin … , influencing crucial pathways related to cholesterol …

[HTML][HTML] NEWS/EVENT

PG Pappas - dit.edu.ng
181 天前 - … Whether Muc2 expression correlates with breast cancer … due statins suppressing
breast cancer cell proliferation and … -carbon metabolism hyper activation works as oncogenesis …